|
TUBGCP4 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.801310E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.157200E-01 |
| Normal-vs-Stage2 |
1.790490E-02 |
| Normal-vs-Stage3 |
4.32470000033547E-07 |
| Normal-vs-Stage4 |
1.70824999999875E-05 |
| Stage1-vs-Stage2 |
1.165190E-01 |
| Stage1-vs-Stage3 |
5.56269999951731E-07 |
| Stage1-vs-Stage4 |
3.83480000000214E-05 |
| Stage2-vs-Stage3 |
4.892100E-02 |
| Stage2-vs-Stage4 |
8.471600E-02 |
| Stage3-vs-Stage4 |
9.783000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.442200E-03 |
| Normal-vs-AfricanAmerican |
1.084470E-03 |
| Normal-vs-Asian |
9.696600E-01 |
| Caucasian-vs-AfricanAmerican |
1.868640E-01 |
| Caucasian-vs-Asian |
3.012000E-01 |
| AfricanAmerican-vs-Asian |
1.652570E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.027300E-04 |
| Normal-vs-Female |
3.356200E-02 |
| Male-vs-Female |
7.259600E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.184170E-02 |
| Normal-vs-Age(41-60Yrs) |
3.337900E-02 |
| Normal-vs-Age(61-80Yrs) |
4.177500E-04 |
| Normal-vs-Age(81-100Yrs) |
3.079000E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.450800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.474800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.937000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.893500E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.048380E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.181200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.245000E-01 |
| Normal-vs-Grade 2 |
1.675770E-01 |
| Normal-vs-Grade 3 |
2.649100E-04 |
| Normal-vs-Grade 4 |
2.4981999802165E-09 |
| Grade 1-vs-Grade 2 |
1.098830E-01 |
| Grade 1-vs-Grade 3 |
7.338400E-03 |
| Grade 1-vs-Grade 4 |
2.1693999999961E-05 |
| Grade 2-vs-Grade 3 |
1.142440E-03 |
| Grade 2-vs-Grade 4 |
2.0864999950021E-08 |
| Grade 3-vs-Grade 4 |
2.215000E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
5.818200E-01 |
| Normal-vs-ccB subtype |
1.995280E-04 |
| ccA subtype-vs-ccB subtype |
2.01739999999839E-05 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.740100E-03 |
| Normal-vs-N1 |
5.522300E-03 |
| N0-vs-N1 |
1.735410E-01 |
|
|
